Naloxone Dosing for Opioid Overdose Reversal
The recommended initial dose of naloxone for opioid overdose reversal is 0.4 mg to 2 mg intravenously, which may be repeated every 2-3 minutes until respiratory function improves. 1, 2
Dosing Guidelines by Route of Administration
Intravenous Administration (Preferred when available)
- Initial dose: 0.4-2 mg
- May repeat every 2-3 minutes as needed
- If no response after 10 mg total, question opioid-induced toxicity diagnosis 1
- For opioid-dependent patients, consider starting with lower doses (0.04-0.4 mg) to minimize withdrawal symptoms 3, 4
Alternative Routes (When IV access unavailable)
- Intramuscular/Subcutaneous: 0.4-2 mg, may repeat every 2-3 minutes 1
- Intranasal: 2 mg, may repeat in 3-5 minutes if necessary 4
- Nebulized: 2 mg diluted in 3 mL normal saline 4
Treatment Algorithm
Assess airway and breathing first
- Focus on supporting airway and breathing before naloxone administration 4
- Begin rescue breathing if necessary
Administer naloxone based on clinical scenario
Reassess after 2-3 minutes
- If inadequate response, repeat dose
- Continue until respiratory function improves
Post-reversal monitoring
Special Considerations
Opioid-Dependent Patients
- Lower initial doses (0.04-0.4 mg) may minimize withdrawal symptoms while still reversing respiratory depression 3, 4
- Titrate carefully to restore adequate respiration without precipitating severe withdrawal
Long-Acting Opioid Overdose
Common Pitfalls to Avoid
Premature discontinuation of monitoring
- Naloxone's duration of action (30-45 minutes) is shorter than many opioids, risking recurrent respiratory depression 2
Delaying emergency response activation
- Always activate emergency services; don't delay while awaiting response to naloxone 2
Administering excessive doses to opioid-dependent patients
Relying solely on naloxone in cardiac arrest
Discharging patients too early
- Patients should be observed until risk of recurrent toxicity is low and vital signs have normalized 4
The evidence consistently supports that naloxone is highly effective for reversing opioid-induced respiratory depression when administered promptly and at appropriate doses. Age may influence dosing requirements, with younger patients potentially needing higher doses 5.